Jyothy Labs Q2 results: Net profit falls 16% to ₹87.76 cr, revenue up 1%

Jyothy Labs' revenue from operations was up marginally at Rs 736.06 crore in the September quarter of FY26. It was at Rs 733.07 crore in the corresponding quarter a year ago

Jyothy Labs
Jyothy Labs | Representative Image
Press Trust of India New Delhi
2 min read Last Updated : Nov 12 2025 | 4:42 PM IST

FMCG firm Jyothy Labs Ltd on Wednesday reported a decline of 16.36 per cent in its consolidated net profit to Rs 87.76 crore in the September quarter of FY26.

It had posted a consolidated net profit of Rs 104.93 crore in the July-September quarter a year ago, according to a regulatory filing by Jyothy Labs, which owns brands such as Ujala, Pril, Margo and Exo.

Jyothy Labs' revenue from operations was up marginally at Rs 736.06 crore in the September quarter of FY26. It was at Rs 733.07 crore in the corresponding quarter a year ago.

This "reflects a 0.4 per cent year-on-year growth in value and 2.8 per cent growth in volume", said Jyothy Labs in its earnings statement.

Its operating EBITDA margin stood at 16.1 per cent, helped by a disciplined cost management despite external headwinds.

Total expenses of Jyothy Labs were at Rs 634.35 crore in the September quarter of FY26.

"General trade continued to remain under pressure. Modern trade, including e-commerce and quick commerce, sustained double-digit growth. Fabric care and dishwashing performed very well in these channels," it said.

Its total revenue, which includes other revenue, was at Rs 753.04 crore in the second quarter, up 1 per cent year-on-year.

Commenting on the results, Chairperson and Managing Director M R Jyothy said: "Q2 was a disciplined step forward in what was a transition quarter. The GST rate revision led to short-term channel adjustments, but our core business remained resilient. We safeguarded profitability through cost discipline and strong cash management, closing the first half with Rs 801 crore in cash and zero debt."  In the first half (H1) of FY26, the total consolidated income of Jyothy Labs was at Rs 1,523.69 crore, up 1.54 per cent.

Over the outlook, she said: "Looking ahead, we expect H2 to perform better than H1, supported by stable commodity costs and a gradual recovery in demand."  Shares of Jyothy Labs Ltd on Wednesday closed at Rs 310.10 apiece on BSE, down 1.05 per cent from the previous close.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :Jyothy LabsJyothy LaboratoriesQ2 results

First Published: Nov 12 2025 | 4:42 PM IST

Next Story